HealthDay News — Tennessee health officials are investigating a cluster of infections tied to a fungus found in soil, after at least 35 people became sick. One death is under review. The illness, ...

HealthDay News — Federal officials have lifted a short pause on more than 100 public health grants worth over $5 billion, allowing states to continue work aimed at strengthening health systems.

HealthDay News — Federal health officials say a milk ingredient used in ByHeart infant formula may be tied to a botulism outbreak that has sickened dozens of babies across the US. On Friday, the Food ...

HealthDay News — The United States has officially pulled out of the World Health Organization (WHO), a year after President Donald Trump announced plans to leave the global health group.

Several medical societies backed the 2026 AAP childhood vaccine schedule, prioritizing longstanding scientific evidence for pediatric public health protocols.

Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

HealthDay News — Six-month smartwatch-based atrial fibrillation (AF) screening improves detection of new-onset AF among patients at elevated stroke risk, according to a study published online January ...

The between-group difference in restricted mean arthritis-free survival time seen at 2 years persisted at 4 years.

TNS seems safe, with no serious adverse events, but no significant differential treatment effects seen versus sham TNS ...

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

New research on acetaminophen use during pregnancy; the chikungunya vaccine Ixchiq is withdrawn; FDA approves Nexplanon for up to 5 years of use; suicidal ideation warning removed from GLP-1s; at-home ...